Therapeutic prospects for paucibacillary leprosy

Indian Journal of Leprosy

Volumn 72, Issue 3, 2000, Pages 351-361

  Katoch, K ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BCG VACCINE; CLARITHROMYCIN; CLOFAZIMINE; ISOPRODIAN; LEPROMIN; LEPROSTATIC AGENT; MINOCYCLINE; OFLOXACIN; PROTIONAMIDE; RIFAMPICIN; STEROID;

BACILLUS; BACTERIAL IMMUNITY; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFICACY; DRUG PROGRAM; FACIAL NERVE PARALYSIS; FOLLOW UP; HUMAN; IMMUNOTHERAPY; LEPROSY; MYCOBACTERIUM LEPRAE; RELAPSE; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CLINICAL TRIALS; DAPSONE; HUMANS; LEPROSTATIC AGENTS; LEPROSY, BORDERLINE; LEPROSY, TUBERCULOID; MINOCYCLINE; OFLOXACIN; POLYPHARMACY; RIFAMPIN;

EID: 0033658164     PISSN: 02549395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Relapses among leprosy patients treated with multidrug therapy: Experience in the leprosy control programme of the All Africa Leprosy and Rehabilitation Training Centre (ALERT) in Ethiopia
2. Experience with multidrug therapy in paucibacillary leprosy
3. Preliminary appraisal of WHO recommended WHO multiple drug regimen in paucibacillary leprosy in Malawi
4. Immunotherapy of lepromin negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy: A six-year follow-up study in Calcutta
5. The Malta experience. Isoprodian-rifampicin combination treatment of leprosy
6. Type of disease in relation to prognosis
7. Short term chemotherapy for paucibacillary leprosy
8. Relapses in paucibacillary leprosy after MDT - A clinical study
9. Pathologic changes in the tibial nerve with surviving M. leprae in a healed tuberculoid leprosy patient
10. Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin
11. Treatment of paucibacillary leprosy with a regimen containing rifampicin, dapsone and prothionamide
12. Response of leprosy patients with single lesions to MDT
13. Chemotherapy trials in PB leprosy using clofazimine
14. Newer investigative techniques for leprosy
15. Is there a microbiological rationale for single-dose treatment of leprosy?
16. Single dose multidrug therapy for the treatment of single lesion PB leprosy
17. Histopathological monitoring of an immunotherapeutic trial with Mycobacterium w
18. Treatment of reaction and nerve damage
19. Multidrug therapy for treatment of paucibacillary leprosy. The western Kenya experience
20. Relapse of paucibacillary leprosy after short course multidrug therapy
21. Minocycline cures tuberculoid leprosy
22. Diagnosis and management of single lesions in leprosy
23. Isoprodian and rifampicin in the treatment of leprosy: A descriptive evaluation of therapy durations in 475 Paraguayan patients
24. Multidrug therapy for paucibacilary leprosy: Experience in Bombay
25. Contribution of Type 1 reactions to the sensory and motor function loss in borderline leprosy patients and the efficacy of treatment with prednisolone
26. Persistance of M. leprae in the peripheral nerve as compared to skin in multidrug treated leprosy patients
27. Efficacy of single dose multidrug therapy for the treatment of single lesion paucibacillary leprosy
28. Discrepancy in the histological features of leprosy lesions in the skin and the peripheral nerve
29. Chemotherapy of leprosy for Control Programmes. Report of a WHO Study Group
30. Expert Committee on Leprosy, Sixth Report
31. Chemotherapy of Leprosy. Report of a WHO Study Group
32. Expert Committee on Leprosy, Seventh Report